Literature DB >> 29859908

Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study.

Nathalie Eckel1, Yanping Li2, Olga Kuxhaus3, Norbert Stefan4, Frank B Hu5, Matthias B Schulze6.   

Abstract

BACKGROUND: Cardiovascular disease risk among individuals across different categories of BMI might depend on their metabolic health. It remains unclear to what extent metabolic health status changes over time and whether this affects cardiovascular disease risk. In this study, we aimed to examine the association between metabolic health and its change over time and cardiovascular disease risk across BMI categories.
METHODS: Between June and December, 1976, 121 701 female nurses were recruited to the Nurses' Health Study (NHS) of whom 103 298 returned a questionnaire in 1980 used as baseline in this study. After excluding women with a history of cardiovascular disease or cancer, with missing body weight and with underweight. 90 257 women were followed-up from 1980 to 2010 for incident cardiovascular disease. Participants were cross-classified by BMI categories, metabolic health (defined by absence of diabetes, hypertension and hypercholesterolaemia), and change in metabolic health status during follow-up. The cardiovascular component of the NHS is registered with ClinicalTrials.gov, number NCT00005152.
FINDINGS: During 2 127  391 person-years of follow-up with a median follow-up of 24 years, we documented 6306 cases of cardiovascular disease including 3304 myocardial infarction cases and 3080 strokes. Cardiovascular disease risk of women with metabolically healthy obesity was increased compared with women with metabolically healthy normal weight (HR 1·39, 95% CI 1·15-1·68), but risk was considerably higher in women with metabolically unhealthy normal weight (2·43, 2·19-2·68), overweight (2·61, 2·36-2·89) and obesity (3·15, 2·83-3·50). The majority of metabolically healthy women converted to unhealthy phenotypes (2555 [84%] of 3027 women with obesity, 22 215 [68%] of 32 882 women with normal-weight after 20 years). Women who maintained metabolically healthy obesity during follow-up were still at a higher cardiovascular disease risk compared with women with stable healthy normal weight (HR 1·57, 1·03-2·38), yet this risk was lower than for initially metabolically healthy women who converted to an unhealthy phenotype (normal-weight 1·90, 1·66-2·17 vs obesity 2·74, 2·30-3·27). Particularly incident diabetes and hypertension increased the risk among women with initial metabolic health.
INTERPRETATION: Even when metabolic health is maintained during long periods of time, obesity remains a risk factor for cardiovascular disease. However, risks are highest for metabolically unhealthy women across all BMI categories. A large proportion of metabolically healthy women converted to an unhealthy phenotype over time across all BMI categories, which is associated with an increased cardiovascular disease risk. FUNDING: US National Institutes of Health, German Federal Ministry of Education and Research.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29859908     DOI: 10.1016/S2213-8587(18)30137-2

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN: 2213-8587            Impact factor:   32.069


  81 in total

1.  A healthy lifestyle pattern is associated with a metabolically healthy phenotype in overweight and obese adults: a cross-sectional study.

Authors:  Farah Naja; Leila Itani; Mona P Nasrallah; Hassan Chami; Hani Tamim; Lara Nasreddine
Journal:  Eur J Nutr       Date:  2019-07-30       Impact factor: 5.614

Review 2.  Metabolically Healthy Obesity and Bariatric Surgery.

Authors:  Adriana Florinela Cătoi; Luca Busetto
Journal:  Obes Surg       Date:  2019-09       Impact factor: 4.129

Review 3.  Obesity, kidney dysfunction and hypertension: mechanistic links.

Authors:  John E Hall; Jussara M do Carmo; Alexandre A da Silva; Zhen Wang; Michael E Hall
Journal:  Nat Rev Nephrol       Date:  2019-06       Impact factor: 28.314

Review 4.  Microvascular Inflammation and Cardiovascular Prevention: The Role of Microcirculation as Earlier Determinant of Cardiovascular Risk.

Authors:  Alessandro Mengozzi; Nicola Riccardo Pugliese; Stefano Masi; Agostino Virdis; Stefano Taddei
Journal:  High Blood Press Cardiovasc Prev       Date:  2021-12-02

Review 5.  Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications.

Authors:  Jun Ren; Ne N Wu; Shuyi Wang; James R Sowers; Yingmei Zhang
Journal:  Physiol Rev       Date:  2021-05-05       Impact factor: 37.312

Review 6.  Obesity and pregnancy, the perfect metabolic storm.

Authors:  Patricia Corrales; Antonio Vidal-Puig; Gema Medina-Gómez
Journal:  Eur J Clin Nutr       Date:  2021-04-28       Impact factor: 4.016

7.  Phthalate exposures and one-year change in body mass index across the menopausal transition.

Authors:  Diana K Haggerty; Jodi A Flaws; Zhong Li; Rita S Strakovsky
Journal:  Environ Res       Date:  2020-12-09       Impact factor: 6.498

Review 8.  Obesity, kidney dysfunction, and inflammation: interactions in hypertension.

Authors:  John E Hall; Alan J Mouton; Alexandre A da Silva; Ana C M Omoto; Zhen Wang; Xuan Li; Jussara M do Carmo
Journal:  Cardiovasc Res       Date:  2021-07-07       Impact factor: 10.787

9.  An Empirically Derived Definition of Metabolically Healthy Obesity Based on Risk of Cardiovascular and Total Mortality.

Authors:  Anika Zembic; Nathalie Eckel; Norbert Stefan; Julia Baudry; Matthias B Schulze
Journal:  JAMA Netw Open       Date:  2021-05-03

10.  Short-Term Changes in Metabolically Healthy Overweight/Obesity Status Impact the Susceptibility to Type 2 Diabetes in Chinese Adults.

Authors:  Jie Min; Xiang Hu; Jiaoyue Zhang; Tianshu Zeng; Ying Wang; Shenghua Tian; Geng Liu; Xueyu Zhong; Kangli Qiu; Miaomiao Peng; Lulu Chen
Journal:  Diabetes Metab Syndr Obes       Date:  2021-06-09       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.